STRYKER CORP (SYK)

Stryker Corporation is a global medical technology company, incorporated in Michigan in 1946 as successor to a business founded in 1941 by Dr. Homer H. Stryker, that designs, manufactures and markets innovative products and services across its MedSurg, Neurotechnology and Orthopaedics businesses, impacting more than 150 million patients annually and selling in approximately 75 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors, marketing primarily to doctors, hospitals and other healthcare facilities. The company operates through two reportable segments: MedSurg and Neurotechnology (60% of 2024 net sales of $22,595 million) and Orthopaedics (40%). The MedSurg and Neurotechnology segment includes Instruments (surgical equipment, patient/caregiver safety technologies and surgical navigation systems), Endoscopy (endoscopic and communications systems, including its 4K 1788 Camera platform), Medical (patient handling, emergency medical equipment, intensive care disposables and the Vocera clinical communication/AI-assisted virtual care platform, including the newly launched LIFEPAK 35 monitor/defibrillator and the acquired care.ai ambient intelligence platform), Neurovascular (minimally invasive devices for treating acute ischemic and hemorrhagic stroke and aneurysms, such as the Surpass Elite and Evolve Flow Diverting Stents) and Neuro Cranial (neurosurgical, craniomaxillofacial, orthobiologic and biosurgery products, spine enabling technologies and interventional spine offerings, bolstered by the acquisition of Vertos Medical for interventional pain management).

The Orthopaedics segment provides implants and specialized instrumentation for total joint replacement (knees, hips, shoulders) and trauma and extremities surgeries, spinal implants, and other orthopaedic products, highlighted by continued global expansion of Mako SmartRobotics (now sold in more than 45 countries, with over one million robotic Mako Total Knee procedures performed), the Triathlon Hinge revision knee system, Direct Anterior Reconstructive Technology, the SERF SAS acquisition strengthening European hip distribution, the first Mako Shoulder procedure, and the new Pangea variable angle plating trauma portfolio. Stryker competes against major global players including Zimmer Biomet, Medtronic, Johnson & Johnson MedTech, Smith & Nephew, CONMED, Karl Storz, Olympus, Baxter, Zoll Medical, Terumo and Penumbra, and its business depends on continued investment in research, innovation and regulatory compliance, holding roughly 5,600 U.S. patents and 8,600 foreign patents as of December 31, 2024, with products subject to FDA and other governmental regulatory oversight in the countries where it operates; raw materials are generally available from multiple sources though some are single-sourced, and while the business is largely non-seasonal, orthopaedic implant surgeries are typically lower in summer months and capital equipment sales are generally higher in the fourth quarter.